BDX Q2 2024 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q2 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5.0B+4.6% YoY

Gross Profit

$2.3B45.7% margin

Operating Income

$734M14.5% margin

Net Income

$537M10.6% margin

EPS (Diluted)

$1.85

QoQ Revenue Growth

+7.2%

Cash Flow

Operating Cash Flow

$515M

Free Cash Flow

$381M

Stock-Based Comp.

$60M

Balance Sheet

Total Assets

$54.2B

Total Liabilities

$28.5B

Stockholders' Equity

$25.6B

Cash & Equivalents

$2.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.0B	$4.8B	+4.6%
Gross Profit	$2.3B	$2.2B	+3.1%
Operating Income	$734M	$628M	+16.9%
Net Income	$537M	$460M	+16.7%

Revenue Segments

Medical

$2.4B49%

Life Sciences

$1.3B26%

Interventional

$1.3B26%

Geographic Segments

UNITED STATES

$2.9B58%

Non-US

$2.1B42%